Related Experiment Video
Updated: Feb 5, 2026

Watershed Planning within a Quantitative Scenario Analysis Framework
Published on: July 24, 2016
The changing scenario of 1
A Russo1, T Franchina1, G R R Ricciardi1
1Medical Oncology Unit A.O. Papardo & Department of Human Pathology, University of Messina, Italy.
Immune checkpoint inhibitors are revolutionizing first-line treatment for advanced Non-Small Cell Lung Cancer (NSCLC). Research is ongoing to optimize their use, patient selection, and identify biomarkers for better outcomes.
Area of Science:
- Oncology
- Immunotherapy
- Thoracic Medicine
Background:
- Front-line treatment for metastatic Non-Small Cell Lung Cancer (NSCLC) has evolved from a generalized approach to histology-based and molecularly-selected strategies.
- The success of immune checkpoint inhibitors (ICIs) in later lines of NSCLC treatment has spurred their investigation in the first-line setting, both as monotherapy and in combination with chemotherapy.
Purpose of the Study:
- To provide a comprehensive overview of the emerging role of immune checkpoint inhibitors in the upfront treatment of advanced NSCLC.
- To discuss the application of ICIs as single agents or in combination therapies for advanced NSCLC without targetable oncogene-addictions.
Main Methods:
- Review of current randomized trials evaluating immune checkpoint inhibitors in the first-line treatment of advanced NSCLC.
- Analysis of preliminary efficacy data and ongoing research into patient selection, optimal treatment strategies (sequential/combinatorial), duration, and biomarker identification.
Main Results:
- Several randomized trials are actively assessing the impact of first-line immune checkpoint inhibitors in advanced NSCLC.
- Preliminary evidence suggests efficacy for ICIs in the first-line setting, although further research is required.
Conclusions:
- Immune checkpoint inhibitors represent a significant advancement in the first-line treatment paradigm for advanced NSCLC.
- Key areas for future research include refining patient selection, optimizing combination and sequential therapeutic approaches, determining appropriate treatment durations, and identifying predictive biomarkers.
Related Concept Videos
Standard Entropy Change for a Reaction
Global Climate Change
Rates of Change
Work Done During Volume Change
Consider a gas confined to a cylinder fitted with a movable piston at one end. If the gas expands from volume V1 to volume V2, it exerts a force on the piston, such that the piston moves by a distance dr.
The work done by the gas on the piston can be expressed as
Le Chatelier's Principle: Changing Temperature
To understand this phenomenon, consider the elementary reaction:
Unsoundness of Aggregate due to Volume Change

